These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
648 related items for PubMed ID: 24982400
1. Induction chemotherapy with docetaxel, cisplatin and fluorouracil followed by surgery and concurrent chemoradiotherapy improves outcome of recurrent advanced head and neck squamous cell carcinoma. Yang WC, Chen CH, Tang JY, Wu CF, Liu YC, Sun Y, Lin SF. Anticancer Res; 2014 Jul; 34(7):3765-73. PubMed ID: 24982400 [Abstract] [Full Text] [Related]
3. Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial. Lorch JH, Goloubeva O, Haddad RI, Cullen K, Sarlis N, Tishler R, Tan M, Fasciano J, Sammartino DE, Posner MR, TAX 324 Study Group. Lancet Oncol; 2011 Feb; 12(2):153-9. PubMed ID: 21233014 [Abstract] [Full Text] [Related]
6. Comparison of induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (TPF) followed by radiation vs concurrent chemoradiotherapy with TPF in patients with locally advanced squamous cell carcinoma of the head and neck. Katori H, Tsukuda M. Clin Oncol (R Coll Radiol); 2005 May; 17(3):148-52. PubMed ID: 15900997 [Abstract] [Full Text] [Related]
10. The Effect of Induction Chemotherapy Using Docetaxel, Cisplatin, and Fluorouracil on Survival in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Meta-Analysis. Kim R, Hahn S, Shin J, Ock CY, Kim M, Keam B, Kim TM, Kim DW, Heo DS. Cancer Res Treat; 2016 Jul; 48(3):907-16. PubMed ID: 26582394 [Abstract] [Full Text] [Related]
12. Concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck. Komatsu M, Shiono O, Taguchi T, Sakuma Y, Nishimura G, Sano D, Sakuma N, Yabuki K, Arai Y, Takahashi M, Isitoya J, Oridate N. Jpn J Clin Oncol; 2014 May; 44(5):416-21. PubMed ID: 24688084 [Abstract] [Full Text] [Related]
13. Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with cisplatin concurrent chemoradiotherapy for nonmetastatic Stage IV head-and-neck squamous cell carcinomas. Prestwich RJ, Öksüz DÇ, Dyker K, Coyle C, Şen M. Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):e237-43. PubMed ID: 21620580 [Abstract] [Full Text] [Related]
16. Induction chemotherapy with dose-modified docetaxel, cisplatin, and 5-fluorouracil in Asian patients with borderline resectable or unresectable head and neck cancer. Wang HM, Lin CY, Hsieh CH, Hsu CL, Fan KH, Chang JT, Huang SF, Kang CJ, Liao CT, Ng SH, Yen TC. J Formos Med Assoc; 2017 Mar 15; 116(3):185-192. PubMed ID: 27133181 [Abstract] [Full Text] [Related]
18. Induction chemotherapy with TPF (Docetaxel, Carboplatin and Fluorouracil) in the treatment of locally advanced squamous cell carcinoma of the head and neck. Schultz JD, Bran G, Anders C, Sadick H, Faber A, Hörmann K, Sauter A. Oncol Rep; 2010 Nov 15; 24(5):1213-6. PubMed ID: 20878112 [Abstract] [Full Text] [Related]
19. A prospective phase II randomized study of docetaxel combined with lobaplatin versus TPF regimen induction chemotherapy followed by concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma. Zhang M, Chen Y, Wu W, Jin F, Li Y, Long J, Luo X, Gong X, Chen X, Liu L, Tang H, Wang Z. J Cancer Res Clin Oncol; 2023 Dec 15; 149(20):18081-18091. PubMed ID: 37985501 [Abstract] [Full Text] [Related]
20. Comparison of carboplatin-paclitaxel to docetaxel-cisplatin-5-flurouracil induction chemotherapy followed by concurrent chemoradiation for locally advanced head and neck cancer. Herman LC, Chen L, Garnett A, Feldman LE, Smith B, Weichselbaum RR, Spiotto MT. Oral Oncol; 2014 Jan 15; 50(1):52-8. PubMed ID: 24055193 [Abstract] [Full Text] [Related] Page: [Next] [New Search]